about
Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesisCollembolan Transcriptomes Highlight Molecular Evolution of Hexapods and Provide Clues on the Adaptation to Terrestrial LifeShrinkBayes: a versatile R-package for analysis of count-based sequencing data in complex study designs.A barcode screen for epigenetic regulators reveals a role for the NuB4/HAT-B histone acetyltransferase complex in histone turnoverThe T7-primer is a source of experimental bias and introduces variability between microarray platformsInsertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypesOne naive T cell, multiple fates in CD8+ T cell differentiation.MicroRNA sequence and expression analysis in breast tumors by deep sequencing.Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.Condensin II mutation causes T-cell lymphoma through tissue-specific genome instabilityHigh Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer.Diagnosis of fanconi anemia: mutation analysis by next-generation sequencingFunctional Screening Identifies Human miRNAs that Modulate Adenovirus Propagation in Prostate Cancer Cells.HELLP babies link a novel lincRNA to the trophoblast cell cycle.Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks.Somatic mutation in PIK3CA is a late event in cervical carcinogenesis.Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment.High-throughput semiquantitative analysis of insertional mutations in heterogeneous tumors.Volatile anesthetics modulate gene expression in breast and brain tumor cells.EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study.Proper genomic profiling of (BRCA1-mutated) basal-like breast carcinomas requires prior removal of tumor infiltrating lymphocytes.Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours.MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing.Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes.Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping.No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.Recruitment of antigen-specific CD8+ T cells in response to infection is markedly efficient.Search for a gene expression signature of breast cancer local recurrence in young women.To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!Novel cases of D-2-hydroxyglutaric aciduria with IDH1 or IDH2 mosaic mutations identified by amplicon deep sequencing.Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.Fetal fraction evaluation in non-invasive prenatal screening (NIPS)Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancerCopy number signatures and mutational processes in ovarian carcinomaGenome-wide microRNA analysis of HPV-positive self-samples yields novel triage markers for early detection of cervical cancer.Molecular heterogeneity in human papillomavirus-dependent and -independent vulvar carcinogenesis.
P50
Q28385225-858BC902-E9DF-4B53-8736-7A034FF8F4F7Q28648435-A80AD22F-8A7D-4DE2-95B3-E17A12D3EE1DQ30809178-1C2043F1-D58C-4C36-8695-A9F3866907E6Q31036616-65410D0B-6765-4CAB-AB65-6E526620B04EQ33330266-E500F6B6-F523-48DD-81CD-FE8F4AD5390CQ33871572-88A99705-657D-4838-BE39-76C8E0A4A3EBQ33902414-D2DCF5F1-89E9-4375-B612-11DD27CAD65AQ34185623-E45266E4-9976-41FA-B02D-C94074B84B67Q34332857-54BDF84F-399C-44E8-BA1E-33814D42CEA5Q34590458-C800C597-5D7A-48E3-9812-68C35A565975Q34679227-6F9D3B31-901A-4D67-B068-12D00F109314Q35777233-52F5AEBE-313F-402B-8D54-35CA529CFF3EQ36031164-A3986454-4AD5-4FF6-92DA-7EF625D05B1BQ36257789-F83C5A13-96AD-4DFA-9087-15B43521D2A5Q36357936-BCC58FD8-456A-459C-B308-8B6C8F70DA34Q36688585-85860731-257A-4F2C-8BFE-DC7DABF02FE8Q37082560-C8C466BD-E619-4233-AD19-FA11B81B4730Q37687487-268DCDDA-4519-4689-8478-2B54F1C3E5DCQ39163315-37465C5B-5338-4EAD-ADB4-0DB16E7966DBQ39476025-28CF1859-9197-4731-BDC3-E039BBB252B2Q39648626-174F933E-1503-4DF4-8551-7506950AECD6Q40129720-695EC04D-7862-4BE0-B2D7-987E72B0B248Q41136344-EDFC94F5-7084-46B0-9E1E-053395789F77Q41238200-C01B529B-DCD5-4580-8D1C-65D8415C8F23Q41262324-3D2AEFA0-76EA-47F3-B0E6-933D4960F784Q42186566-C0797F07-CA71-447F-9EA1-D28676D5E7FFQ42199595-A7E6784E-F676-4214-B28F-F215ECD1697BQ42263135-658EA443-8E5B-4B9A-8854-89443670C0B8Q43281147-97617ABF-19CC-44BA-B542-30CE4AEE3568Q43589450-A95991DE-00CD-441C-99F2-7AA66918FCCBQ44207301-72207367-F821-4A65-A5D0-4E40B426BC8DQ44457947-9ABB1FFB-6823-47E0-B2E3-07C92FDB98CFQ55071303-68F34802-D7E7-4C71-A07A-B9335B0B7DEAQ57774992-0E31329C-FA58-49F1-A166-B50F10B837A9Q58802479-81705E42-3A42-45DF-AD24-082BDBFB357FQ61757402-39DF59EF-3C2C-41E8-A854-F00DAAC4140CQ64889875-1E117C4D-7537-48DA-81CC-18AEC089806DQ64899986-609D696E-3BA4-4609-9A17-873AD072A832
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daoud Sie
@ast
Daoud Sie
@en
Daoud Sie
@es
Daoud Sie
@nl
Daoud Sie
@sl
type
label
Daoud Sie
@ast
Daoud Sie
@en
Daoud Sie
@es
Daoud Sie
@nl
Daoud Sie
@sl
prefLabel
Daoud Sie
@ast
Daoud Sie
@en
Daoud Sie
@es
Daoud Sie
@nl
Daoud Sie
@sl
P106
P21
P31
P496
0000-0001-6762-2582